J&J ‘very confident’ in vaccine, eyes quick resolution
Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday.
by ·
Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday.
by · Published June 10, 2021
by · Published April 19, 2021
by · Published May 4, 2021